BIO
Alex Gee
Senior Director, Market Access
Alex is senior director with particular expertise in a range of pricing and market access projects.
Alex has run and moderated multiple primary research driven projects in the US and Europe, ranging from early phase in rare diseases through to generic defense for blockbuster brands. Most recently, Alex ran and moderated multi-stakeholder advisory boards with a focus on commercial positioning.
Additionally, his experience include value message development, quantitative and qualitative market research, payer evidence planning, commercialization, and market access strategy across a range of disease areas. Alex has extensive experience in a range of therapeutic areas, including respiratory and cardiovascular diseases, dermatology, diabetes and rare diseases.
Prior to joining pharma, Alex gained a degree in Genetics and spent 3 years working in the NHS assessing clinical effectiveness.